US FDA Registration for Foreign Companies: Complete Compliance Guide (2026)

Entering the U.S. market can create major opportunities for pharmaceutical, medical device, food, cosmetic, and other regulated-product companies. However, selling products in the United States requires more than simply shipping products to American customers.

Foreign companies need to understand which FDA requirements apply to their specific product, facility, and business model. Depending on the product category, requirements may include facility registration, product listing, establishment registration, U.S. Agent designation, premarket submissions, labeling compliance, import requirements, and ongoing regulatory obligations.

For companies planning U.S. expansion, understanding FDA registration for foreign companies is an important first step toward building a compliant market-entry strategy.

Does Every Foreign Company Need FDA Registration?

There is no single FDA registration that applies to every foreign company.

The U.S. Food and Drug Administration regulates different product categories through different regulatory programs. FDA’s registration and listing requirements vary for food, drugs, medical devices, cosmetics, tobacco products, animal products, and other regulated products.

For example:

  • Foreign drug establishments may need establishment registration and drug listing.
  • Foreign food facilities that manufacture, process, pack, or hold food for U.S. consumption generally need food facility registration unless an exemption applies.
  • Foreign medical device establishments involved in producing or distributing devices intended for the U.S. market generally need establishment registration.
  • Certain cosmetic businesses have requirements under the Modernization of Cosmetics Regulation Act (MoCRA).
  • Other regulated products have their own FDA requirements.

Therefore, the first step is determining the regulatory category that applies to your product.

FDA Registration Is Not the Same as FDA Approval

This distinction is critical for foreign businesses.

FDA registration generally means that a facility or establishment has been registered with the agency as required by the applicable regulatory program.

Registration does not automatically mean that FDA has approved the company, facility, or product.

For example, FDA explains that a food facility registration number does not constitute FDA approval or endorsement of the facility or its products.

Similarly, some medical devices may require a premarket submission or authorization in addition to establishment registration and device listing.

Therefore, businesses should avoid treating “FDA registered” as equivalent to “FDA approved.”

FDA Registration Requirements Depend on Product Category

Before beginning the FDA registration process, a foreign company should identify the regulatory pathway for its product.

Pharmaceutical and Drug Products

Foreign establishments that manufacture, repack, or relabel drugs for the U.S. market generally have registration and drug-listing obligations. FDA states that foreign drug establishments whose products are imported or offered for import into the United States must register and list applicable commercially distributed drug products.

Depending on the product, additional requirements may include:

  • Drug establishment registration
  • Drug listing
  • Labeling requirements
  • New Drug Application (NDA)
  • Abbreviated New Drug Application (ANDA)
  • Current Good Manufacturing Practice requirements
  • Import requirements
  • Post-market obligations

Registration alone does not replace applicable drug approval requirements.

Medical Devices

Foreign medical device companies may need to register their establishments and list applicable devices with FDA.

FDA identifies establishment registration as a requirement for owners or operators of places of business involved in the production and distribution of medical devices intended for use in the United States.

Depending on device classification and intended use, the company may also need an applicable premarket pathway, such as:

  • 510(k)
  • De Novo
  • Premarket Approval (PMA)
  • Other applicable submission or exemption

Foreign establishments also need to identify a U.S. Agent as part of the registration process. FDA states that a foreign establishment may designate only one U.S. Agent.

Food Products

Foreign food facilities that manufacture, process, pack, or hold food for consumption in the United States generally must register with FDA unless an applicable exemption applies.

Food businesses may also need to address:

  • Prior Notice
  • Food labeling
  • Food safety requirements
  • Preventive controls
  • Import requirements
  • Facility information
  • U.S. Agent requirements

FDA also conducts inspections of foreign food facilities to assess compliance and help determine the admissibility of products entering the United States.

What Is a U.S. Agent?

For many foreign facilities, designation of a U.S. Agent is an important part of the FDA regulatory process.

A U.S. Agent can serve as a communication point between the foreign establishment and FDA.

For foreign food facilities, FDA requires the designated U.S. Agent to live or maintain a place of business in the United States and be physically present in the United States.

Medical device foreign establishments similarly need to identify a U.S. Agent during establishment registration.

The exact role and responsibilities of the U.S. Agent depend on the applicable FDA program.

Foreign companies should therefore select their U.S. Agent carefully rather than treating the designation as a simple administrative formality.

Step-by-Step FDA Registration Process

Although requirements vary by product category, a typical FDA registration process can involve several stages.

Step 1: Identify the Product Category

First determine whether the product is regulated as a:

  • Drug
  • Medical device
  • Food
  • Cosmetic
  • Dietary supplement
  • Biologic
  • Animal product
  • Other FDA-regulated product

This classification determines the regulatory pathway.

Step 2: Determine Applicable FDA Requirements

The company should identify whether it needs:

  • Facility registration
  • Product listing
  • Establishment registration
  • U.S. Agent
  • Premarket authorization
  • Product-specific submissions
  • Labeling compliance
  • Import documentation
  • Post-market reporting

This step prevents companies from assuming that registration alone is sufficient.

Step 3: Gather Company and Facility Information

Depending on the FDA program, information may include:

  • Legal company name
  • Facility name
  • Physical address
  • Contact information
  • Manufacturing activities
  • Product information
  • Owner or operator details
  • U.S. Agent information
  • Product categories
  • Applicable identification numbers

FDA registration systems require accurate facility information. For example, FDA systems may require facility identifiers and specific establishment information depending on the product category.

Step 4: Appoint a U.S. Agent Where Required

Foreign companies subject to a U.S. Agent requirement should designate an appropriate U.S.-based representative.

The U.S. Agent may be responsible for receiving communications and performing other functions established by the applicable FDA program.

FDA may verify that the designated U.S. Agent has agreed to serve in that role.

Step 5: Complete the Registration

The company then submits the required information through the applicable FDA system.

The registration process differs by product category, so businesses should use the correct FDA platform and submission procedure.

Step 6: Complete Product Listing or Premarket Requirements

Where applicable, registration must be followed by product listing or the appropriate premarket pathway.

For drugs, registered establishments generally must list commercially distributed drug products.

For medical devices, establishment registration and device listing requirements may apply along with a separate premarket submission when required.

FDA Import Compliance

FDA registration is only one part of entering the United States.

Products regulated by FDA are subject to review when offered for import into the country. FDA states that imported FDA-regulated products must comply with applicable U.S. laws and regulations, and noncompliant products may be refused admission.

Import entry information can include:

  • Product information
  • Product code
  • Manufacturer
  • Shipper
  • Importer
  • Country of origin
  • Applicable FDA affirmations
  • Estimated arrival information
  • Other product-specific information

This means a company can have an FDA registration but still encounter import problems if its products, documentation, labeling, or entry information do not meet applicable requirements.

Why U.S. Market Entry Requires More Than Registration

A foreign company entering the United States should view FDA registration as part of a broader regulatory strategy.

The US market entry regulatory pathway can involve several stages:

Product classification → Regulatory assessment → Registration → Product listing or premarket submission → Labeling review → Import compliance → Post-market compliance

The exact pathway depends on the product.

A medical device manufacturer, pharmaceutical company, and food manufacturer cannot simply follow the same registration procedure.

Common Mistakes Foreign Companies Make

Assuming Registration Means Approval

FDA registration does not automatically mean FDA has approved the product.

Choosing the Wrong Regulatory Category

Incorrect product classification can result in the wrong regulatory pathway.

Ignoring U.S. Agent Requirements

Foreign establishments subject to U.S. Agent requirements need to provide accurate U.S. Agent information.

Focusing Only on Registration

A company may complete facility registration but overlook labeling, product listing, premarket authorization, import, or post-market requirements.

Submitting Inaccurate Information

Inconsistent company, facility, product, or U.S. Agent information can create regulatory complications.

Ignoring Import Requirements

FDA reviews regulated products offered for entry into the United States. Accurate import information and compliance documentation are therefore important.

Why Work With a US FDA Compliance Consultant?

For companies unfamiliar with the U.S. regulatory environment, working with a US FDA compliance consultant can help clarify the requirements before entering the market.

Regulatory support can include:

  • Product classification
  • FDA regulatory pathway assessment
  • Facility registration
  • Product listing
  • U.S. Agent coordination
  • Premarket submission support
  • Labeling review
  • Import compliance
  • Documentation review
  • Regulatory strategy
  • Post-market compliance

The goal is to identify regulatory requirements before they become barriers to market entry.

How CliniExperts Can Help Foreign Companies

CliniExperts provides international regulatory consulting support for companies seeking access to the U.S. market.

A structured regulatory assessment can help foreign manufacturers understand which FDA requirements apply to their specific products and facilities.

Support can include FDA registration for foreign companies, regulatory pathway assessment, documentation, U.S. Agent coordination, product listing, compliance strategy, and other market-entry activities.

For businesses entering the U.S. for the first time, having a regulatory plan before commercial distribution can help reduce avoidable delays and compliance risks.

2026 FDA Compliance Considerations

FDA requirements continue to evolve across different regulated product categories.

Foreign companies should monitor changes affecting:

  • Registration requirements
  • Product listings
  • U.S. Agent information
  • Facility information
  • Labeling
  • Premarket submissions
  • Import procedures
  • Manufacturing requirements
  • Post-market obligations

Businesses should rely on current FDA requirements applicable to their specific product rather than assuming that an older registration strategy remains sufficient.

Conclusion

For foreign manufacturers, entering the United States requires more than obtaining an FDA registration number.

The correct approach begins with identifying the product category and understanding the applicable regulatory pathway. Depending on the product, a company may need facility registration, product listing, U.S. Agent designation, premarket authorization, labeling compliance, import documentation, and ongoing post-market responsibilities.

The FDA registration process therefore needs to be considered as part of a broader compliance strategy rather than as a standalone administrative requirement.

Companies planning US market entry regulatory activities should also understand that FDA registration does not automatically constitute product approval. FDA confirms that registration and listing requirements vary by product category, while imported products must meet applicable U.S. requirements before they can enter the market.

With the support of an experienced US FDA compliance consultant, foreign companies can assess their regulatory pathway, prepare the required documentation, manage registration and listing requirements, and build a more structured strategy for entering the U.S. market.